Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

NCT02178670 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms,Ovarian

Interventions

BIOLOGICAL: CSC-DC

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]